Business
MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results
MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results Canada NewsWir...
About this update from Medipharm Labs Corp.
[{"type":"text","content":"\n\n\n\n MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n\n TORONTO\n \n\n ,\n \n\n Aug. 8, 2024\n \n\n /CNW/ -\n \n MediPharm Labs Corp.\n \n (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (\"MediPharm\", \"MediPharm Labs\" or the \"Company\") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its second quarter financial results for the period ended\n \n June 30, 2024\n \n , before markets open on\n \n Wednesday, August 14, 2024\n \n .\n \n\n\n\n\n\n\n\n\n MediPharm Labs executive management team will also host a conference call and audio webcast on\n \n Wednesday, August 14, 2024\n \n , at\n \n 8:30 a.m. (Eastern time)\n \n to discuss the Company's financial results.\n \n\n\n Audio Conference Call Dial in Details:\n \n\n\n North\n \n America Toll-Free\n \n : (888) 330-2454\n \n\n International Toll: +1(240) 789-2714\n \n\n Conference ID: 4921762\n \n\n Participants are asked to dial in approximately 15 minutes before the start of the call.\n \n\n\n Audio Webcast:\n \n\n\n An audio webcast will be available by visiting the following link\n \n here\n \n .\n \n\n For those who are unable to participate on the live conference call or webcast, a replay will be available at\n \n https://www.medipharmlabs.com/investors\n \n approximately one day after completion of the call.\n \n\n\n About MediPharm Labs\n \n\n\n Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities for delivery of pure, trusted and precision-dosed cannabis products for its customers. MediPharm Labs develops, formulates, pro...